Multifocal motor neuropathy is not associated with altered innate immune responses to endotoxin

Jeroen W Bos1, Ewout J N Groen1, Kevin Budding2

  • 1Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht University, Utrecht, the Netherlands.

Abstract

Insights

Innate immune responses to endotoxin do not appear to be a risk factor for Multifocal Motor Neuropathy (MMN). Baseline protein levels, however, correlated with intravenous immunoglobulin (IVIg) dosage in MMN patients.

Area of Science:

  • Immunology
  • Neurology

Background:

  • Multifocal Motor Neuropathy (MMN) pathogenesis involves antibody- and complement-mediated peripheral nerve inflammation.
  • Understanding innate immune responses to endotoxin may reveal MMN risk factors and disease modifiers.

Purpose of the Study:

  • To investigate innate immune responses to endotoxin in MMN patients and controls.
  • To identify potential risk factors and disease modifiers in MMN.

Main Methods:

  • Whole blood from 52 MMN patients and 24 controls was stimulated with endotoxin (lipopolysaccharide, LPS).
  • Plasma levels of key immunoregulating proteins (IL-1RA, IL-1β, IL-6, IL-10, IL-21, TNF-α, IL-8, CD40L) were measured using a multiplex assay.
  • Baseline and stimulated protein levels were compared between groups and correlated with clinical parameters.

Main Results:

  • Endotoxin stimulation resulted in comparable protein level changes between MMN patients and controls.
  • Baseline concentrations of IL-1RA, IL-1β, IL-6, and IL-21 positively correlated with monthly intravenous immunoglobulin (IVIg) dosage.
  • Patients with anti-GM1 IgM antibodies exhibited a more pronounced increase in IL-21 after stimulation.

Conclusions:

  • Altered endotoxin-induced innate immune responses are unlikely to be a susceptibility factor for MMN.
  • Specific baseline protein levels may be associated with IVIg treatment intensity in MMN.